Lymphocytes Subpopulation in Cancer Patients
- Conditions
- Cancer
- Interventions
- Other: lymphocyte
- Registration Number
- NCT02516371
- Lead Sponsor
- DERSHENG SUN
- Brief Summary
This study aims to exam the subpopulation of lymphocytes and evaluate the clinico-pathologic correlations.
- Detailed Description
The host's inflammatory response in the tumor microenvironment could effect cancer progression and prognosis. As components of systemic inflammatory response, lymphocytes, neutrophils, and platelets are being recognised to have an important role in carcinogenesis and tumor progression. To date, a number of peripheral blood-derived inflammation-based scores such as the neutrophil-lymphocyte ratio (NLR), platelet- lymphocyte ratio (PLR) and so on have been proposed as prognostic markers in numerous types of cancers. But, very little is known of their impact in subpopulation of lymphocytes. The investigators try to evaluate the activity of lymphocytes in peripheral blood and find out the relationship among clinical prognosis.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- cancer patients of Uijeongbu St. Mary's Hospital
- never treated with chemotherapy
- Age between 20~80 years-
- treated with chemotherapy before
- No informed consent form
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description lymphocytes lymphocyte To evaluate the subpopulation of lymphocytes in cancer patients
- Primary Outcome Measures
Name Time Method response rate after cancer treatment with chemotherapy 6 months after chemotherapy
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Uijeongbu St. Mary's hospital, the Catholic university of Korea
🇰🇷Uijeongbu city, Gyounggido, Korea, Republic of